ClinicalTrials.Veeva

Menu

Aneuploidy Rate and Stimulation Protocol: Recombinant Follicle Stimulating Hormone (FSH) Versus Human FSH

I

IVI Madrid

Status

Terminated

Conditions

Aneuploidy Rate

Treatments

Procedure: Stimulation with human FSH
Procedure: Stimulation with recombinant FSH

Study type

Interventional

Funder types

Other

Identifiers

NCT01164943
MAD-FB-04-2010-01

Details and patient eligibility

About

Several stimulation protocols have been used in in vitro fertilization (IVF) in a cycle of egg donation; recombinant FSH and human FSH are included. The effect of each kind of hormone on aneuploidy rate it is unknown. If there was an increase on aneuploidy rate of one of these stimulation protocols, there will be a negative effect on the successful rates in the egg donation cycles. The aim of this study is to observe if there is a different in aneuploidy rate and morphological oocyte parameters between different stimulation protocols.

Enrollment

80 patients

Sex

All

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Egg donation cycles with more than 8MII in oocyte retrieval day

Exclusion criteria

  • Male factor
  • Uterine malformations
  • genetic alterations

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

80 participants in 2 patient groups

Human FSH
Active Comparator group
Treatment:
Procedure: Stimulation with human FSH
Recombinant FSH
Active Comparator group
Treatment:
Procedure: Stimulation with recombinant FSH

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems